Phosphalohydrins and methods for medicinal administration
申请人:Institut National de la Sante et de la Recherche Medicale
公开号:US06660723B1
公开(公告)日:2003-12-09
The invention provides compounds comprising at least one phosphohalohydrin group of the formula:
where X is a halogen selected from among I, Br, Cl,
R1 is selected from among —CH3 and —CH2—CH3,
Cat+ is an organic or inorganic cation,
and n is an integer between 2 and 20,
processes for the production thereof and uses thereof, in particular therapeutic uses and for activating primate T&ggr;9&dgr;2 lymphocytes.